Federal Preemption Defense Under Fire In Draft House Bills
This article was originally published in The Gray Sheet
Executive Summary
A one-sentence provision tucked into draft legislation circulating in a House subcommittee seeks to weaken device and drug manufacturers' ability to claim FDA approval as a defense in state product liability lawsuits